These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 20568389)

  • 1. Omalizumab monotherapy for bee sting and unprovoked "anaphylaxis" in a patient with systemic mastocytosis and undetectable specific IgE.
    Kontou-Fili K; Filis CI; Voulgari C; Panayiotidis PG
    Ann Allergy Asthma Immunol; 2010 Jun; 104(6):537-9. PubMed ID: 20568389
    [No Abstract]   [Full Text] [Related]  

  • 2. Beekeepers anaphylaxis: successful immunotherapy covered by omalizumab.
    Schulze J; Rose M; Zielen S
    Allergy; 2007 Aug; 62(8):963-4. PubMed ID: 17484729
    [No Abstract]   [Full Text] [Related]  

  • 3. Omalizumab for the treatment of unprovoked anaphylaxis in patients with systemic mastocytosis.
    Carter MC; Robyn JA; Bressler PB; Walker JC; Shapiro GG; Metcalfe DD
    J Allergy Clin Immunol; 2007 Jun; 119(6):1550-1. PubMed ID: 17481708
    [No Abstract]   [Full Text] [Related]  

  • 4. Severe anaphylaxis to bee venom immunotherapy: efficacy of pretreatment and concurrent treatment with omalizumab.
    Galera C; Soohun N; Zankar N; Caimmi S; Gallen C; Demoly P
    J Investig Allergol Clin Immunol; 2009; 19(3):225-9. PubMed ID: 19610266
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Omalizumab mitigates anaphylaxis during ultrarush honey bee venom immunotherapy in monoclonal mast cell activation syndrome.
    da Silva EN; Randall KL
    J Allergy Clin Immunol Pract; 2013; 1(6):687-8. PubMed ID: 24565720
    [No Abstract]   [Full Text] [Related]  

  • 6. Omalizumab is effective in treating systemic mastocytosis in a nonatopic patient.
    Douglass JA; Carroll K; Voskamp A; Bourke P; Wei A; O'Hehir RE
    Allergy; 2010 Jul; 65(7):926-7. PubMed ID: 19889117
    [No Abstract]   [Full Text] [Related]  

  • 7. What's eating you? Bees, Part 2: Venom immunotherapy and mastocytosis.
    Lewis FS; Smith LJ
    Cutis; 2007 Jul; 80(1):33-7. PubMed ID: 17725061
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anaphylaxis after hymenoptera sting: is it venom allergy, a clonal disorder, or both?
    Castells MC; Hornick JL; Akin C
    J Allergy Clin Immunol Pract; 2015; 3(3):350-5. PubMed ID: 25858055
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nonaggressive systemic mastocytosis (SM) without skin lesions associated with insect-induced anaphylaxis shows unique features versus other indolent SM.
    Alvarez-Twose I; Zanotti R; González-de-Olano D; Bonadonna P; Vega A; Matito A; Sánchez-Muñoz L; Morgado JM; Perbellini O; García-Montero A; De Matteis G; Teodósio C; Rossini M; Jara-Acevedo M; Schena D; Mayado A; Zamò A; Mollejo M; Sánchez-López P; Cabañes N; Orfao A; Escribano L; ;
    J Allergy Clin Immunol; 2014 Feb; 133(2):520-8. PubMed ID: 23921094
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IgE-mediated anaphylaxis to Hippobosca equina in a patient with systemic mastocytosis.
    Matito A; Bartolomé-Zavala B; Alvarez-Twose I; Sánchez-Matas I; Escribano L
    Allergy; 2010 Aug; 65(8):1058-9. PubMed ID: 20002662
    [No Abstract]   [Full Text] [Related]  

  • 11. Safety and effectiveness of immunotherapy in patients with indolent systemic mastocytosis presenting with Hymenoptera venom anaphylaxis.
    González de Olano D; Alvarez-Twose I; Esteban-López MI; Sánchez-Muñoz L; de Durana MD; Vega A; García-Montero A; González-Mancebo E; Belver T; Herrero-Gil MD; Fernández-Rivas M; Orfao A; de la Hoz B; Castells MC; Escribano L
    J Allergy Clin Immunol; 2008 Feb; 121(2):519-26. PubMed ID: 18177694
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A shock reaction from insect bites in patients with urticaria pigmentosa].
    Poroshina IuA; Gushchin IS; Chitaeva VG; Shvets SM; Zernov AA
    Ter Arkh; 1995; 67(10):33-5. PubMed ID: 8779101
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Results of desensitization with allpyral extracts in bee and wasp sting allergies].
    Wortmann F
    Schweiz Med Wochenschr; 1969 Jul; 99(27):974-6. PubMed ID: 5805592
    [No Abstract]   [Full Text] [Related]  

  • 14. Failure of omalizumab treatment after recurrent systemic reactions to bee-venom immunotherapy.
    Soriano Gomis V; Gonzalez Delgado P; Niveiro Hernandez E
    J Investig Allergol Clin Immunol; 2008; 18(3):225-6. PubMed ID: 18564638
    [No Abstract]   [Full Text] [Related]  

  • 15. Hymenoptera venom allergy.
    Przybilla B; Ruëff F
    J Dtsch Dermatol Ges; 2010 Feb; 8(2):114-27; quiz 128-30. PubMed ID: 19751222
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systemic mastocytosis presenting as IgE-mediated food-induced anaphylaxis: A report of two cases.
    Prieto-García A; Álvarez-Perea A; Matito A; Sánchez-Muñoz L; Morgado JM; Escribano L; Álvarez-Twose I
    J Allergy Clin Immunol Pract; 2015; 3(3):456-8. PubMed ID: 25687289
    [No Abstract]   [Full Text] [Related]  

  • 17. Allergic reactions following first insect sting exposure.
    Reisman RE; Osur SL
    Ann Allergy; 1987 Dec; 59(6):429-32. PubMed ID: 3425982
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Death after bee-sting].
    Nowak R; Gottlöber P; Peter RU
    Hautarzt; 2003 Apr; 54(4):348-50. PubMed ID: 12669207
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Omalizumab induced remission of idiopathic anaphylaxis in a patient suffering from indolent systemic mastocytosis.
    Kibsgaard L; Skjold T; Deleuran M; Vestergaard C
    Acta Derm Venereol; 2014 May; 94(3):363-4. PubMed ID: 24162824
    [No Abstract]   [Full Text] [Related]  

  • 20. Reduction of the total IgE level by omalizumab in children and adolescents.
    Steiss JO; Strohner P; Zimmer KP; Lindemann H
    J Asthma; 2008 Apr; 45(3):233-6. PubMed ID: 18415832
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.